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Abstract
Infection of mice with murine gammaherpesvirus 68 (MHV68) provides a tractable small animal model to study various
aspects of persistent gammaherpesvirus infection. We have previously utilized a transgenic MHV68 that expresses enhanced
yellow fluorescent protein (EYFP) to identify infected cells. While this recombinant MHV68 has been useful for identifying
infected cell populations by flow cytometry, it has been suboptimal for identification of infected cells in tissue sections due
to the high solubility of EYFP. Efficient detection of EYFP expressed from the MHV68 genome in tissue sections requires
fixation of whole organs prior to sectioning, which frequently leads to over-fixation of some cellular antigens precluding
their detection. To circumvent this issue, we describe the generation and characterization of a transgenic MHV68 harboring
a fusion gene composed of the EYFP coding sequence fused to the histone H2B open reading frame. Because the H2bYFP
fusion protein is tightly bound in nucleosomes in the nucleus it does not freely diffuse out of unfixed tissue sections, and
thus eliminates the need for tissue fixation. We have used the MHV68-H2bYFP recombinant virus to assess the location and
distribution of virus infected B cells in germinal centers during the peak of MHV68 latency in vivo. These analyses show that
the physical location of distinct populations of infected germinal center B cells correlates well with their surface phenotype.
Furthermore, analysis of the distribution of virus infection within germinal center B cell populations revealed that ca. 70% of
MHV68 infected GC B cells are rapidly dividing centroblasts, while ca. 20% have a clear centrocyte phenotype. Finally, we
have shown that marking of infected cells with MHV68-H2bYFP is extended long after the onset of latency – which should
facilitate studies to track MHV68 latently infected cells at late times post-infection.
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Introduction
Murine gammaherpesvirus 68 (MH68) infection of mice is a
small animal model that has been useful in addressing basic aspects
of gammaherpesvirus pathogenesis. MHV68 is related to the
human gammaherpesviruses Epstein-Barr virus (EBV) and human
herpesvirus 8 (HHV-8; also known as Kaposi’s sarcoma associated
herpesvirus [KSHV]) – both of which exhibit a very narrow host
tropism and thus have been difficult to study in vivo [1]. As such,
infection of mice with MHV68 allows the study of gammaher-
pesvirus pathogenesis during the establishment of infection that
cannot be addressed for the human viruses. However, one
difficulty in studying MHV68 infection is the low frequency of
virally infected cells. At the peak of latency in the spleen, the
frequency of infected cells is less than 1% of total splenocytes [2–
4]. Further complicating the analysis of latently infected cells is
that there is minimal viral gene transcription. In an effort to
identify infected cells in vivo, we previously constructed a transgenic
virus, MHV68-YFP, that expresses the enhanced yellow fluores-
cent protein (EYFP) from an expression cassette cloned into the
intergenic region between orfs 27 and 29b [4]. This virus has
proven to be useful for: (i) identifying infected cells early during the
establishment of latency [4], (ii) tracking changes in infected cell
populations when specific viral genes are knocked out [5], (iii)
tracking populations of infected cells in knockout strains of mice
[6], and (iv) monitoring infection in vitro [7,8].
Although MHV68-YFP has been useful in identifying infected
cells during the early establishment of latency, one limitation of
this recombinant virus is that it is not very useful for identifying
infected cells in tissue sections based on EYFP expression. This
appears to be directly related to the high solubility of fluorescent
proteins such as EYFP. Thus, when trying to identify infected cells
in tissue sections based on EYFP expression extensive fixation is
required using reagents, such as paraformaldehyde, that cross-link
EYFP to cellular proteins to preserve the EYFP signal. In the
absence of cross-linking, EYFP freely diffuses out of tissue sections.
While small organs such as lymph nodes do not require prolonged
fixation, larger organs such as the spleen require extensive fixation.
This often results in over-fixation of cellular antigens, resulting in
signal loss. Furthermore, this prolonged fixation often makes
spleens rigid and difficult to section. These issues have previously
been resolved by perfusion of whole animals with paraformalde-
hyde [9] which preserves detection of EYFP in tissue section, but is
gentle enough to preserve detection of cellular antigens. However,
this results in fixation of the entire spleen and precludes recovery
of a portion of unfixed spleen for experimental analyses requiring
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dilution analyses). Because of these issues, we pursued develop-
ment of a strategy to detect infected cells in tissue sections without
the complications that arise from the need for fixation.
A further limitation of the MHV68-YFP recombinant virus is
that EYFP expression quickly wanes after the onset of latency [4].
This is most likely due to epigenetic modification of the region of
the MHV68 genome that the EYFP expression cassette is cloned
into. Notably, this region of the viral genome encodes genes that
are only expressed during the lytic cycle and are not expressed
during latency [10,11]. Various strategies to extend transgene
expression, including the use of other viral promoters (SV40 early
promoter), cellular house-keeping gene promoters (ubiquitin C
and e1f-alpha promoters), and herpesvirus promoters that are
known to be active during latency (KSHV PAN promoter), have to
date been universally unsuccessful in marking latently infected cells
in vivo (Collins, Morales & Speck, unpublished data). Additionally,
cloning an EYFP expression cassette into a region of the viral
genome that is transcriptionally active during the early stages of
MHV68 latency also failed to mark latently infected cell
populations (Collins & Speck, unpublished data).
Fusion proteins consisting of histone H2B and fluorescent
proteins have been used to label nuclei for tracking cells, and in
studies on cell division and replication history [12–14]. These
fusion proteins are incorporated into nucleosomes, allowing direct
visualization of the chromatin in living tissues. Because these
fusions are bound in nucleosomes in the nucleus, we hypothesized
that this would restrict the mobility of EYFP, thereby eliminating
the need to fix spleen sections. Additionally, it has been shown that
a histone H2B-GFP fusion remains stable for many weeks in vivo in
populations of slowly cycling cells [12]. Because MHV-68 has
been shown to establish long term latency in memory B cells, a
population of cells that divide only sporadically, we reasoned that
expression of the H2bYFP fusion protein would extend marking of
latently infected cells long after transcription of the H2bYFP
transgene from the viral genome had been shut down. Here we
show that a recombinant virus, MHV68-H2bYFP, which
expresses a histone H2bYFP fusion protein can be used to detect
infected cells in unfixed spleen sections. Furthermore, we show
that the physical location of infected cells in these sections
correlates with the surface phenotype as determined by flow
cytometry. Additionally, we show that MHV68-H2bYFP is able to
efficiently mark cells at late times post-infection.
Results and Discussion
Construction of recombinant MHV68 expressing an
H2bYFP fusion protein
To create a transgenic virus that will allow detection of infected
cells in unfixed tissue sections, we cloned an expression cassette
that expresses a fusion protein consisting of histone H2B and
EYFP into the region between orfs 27 and 29b of the MHV68
genome (MHV68-H2bYFP) (fig. 1A). We have previously cloned
expression cassettes into this region of the viral genome with no
detectable effect on the ability of the virus to replicate or establish
persistent infection [4,15]. Correct insertion of the H2bYFP fusion
gene was confirmed by PCR with primers specific for the fusion
gene, as well as gel electrophoresis of purified DNA digested with
diagnostic restriction enzymes. Figure 1B shows fluorescent
protein expression in viral plaques formed on virus infected
NIH3T12 cells at 48 hours post-infection with either MHV68-
YFP (left-hand panel) or MHV68-H2bYFP (right-hand panel). In
cells infected with MHV68-YFP, EYFP is diffusely distributed
throughout both the cytoplasm and nucleus. However, in cells
Figure 1. Construction of MHV68-H2bYFP. A) An expression cassette that expresses a histone H2bYFP fusion protein was cloned into the
intergenic region between ORFs 27 and 29b. The cassette was flanked by chromatin insulators (XL9CD) as previously described [4] B). Representative
plaques formed on NIH3T12 cells infected with either MHV68-YFP (left panel) or MHV68-H2bYFP (right panel) at 48 hours post-infection. In cells
infected with MHV68-YFP, YFP has a diffuse localization that can be detected throughout infected cells, whereas YFP signal in cells infected with
MHV68-H2bYFP is restricted to the nucleus.
doi:10.1371/journal.pone.0033230.g001
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fusion protein is restricted to the nucleus.
Expression of H2bYFP does not alter latency
To ensure that expression of the H2bYFP fusion protein had no
impact on the ability of the virus to establish latency, mice were
infected intranasally with 1,000 pfu of virus and splenocytes were
harvested at 16 days post-infection. Limiting dilution PCR
analyses showed that the frequency of viral genome positive
splenocytes from mice infected with MHV68-H2bFYP was similar
to both wild type virus and MHV68-YFP (Fig. 2A). Approximately
1 in 95 splenocytes from mice infected with MHV68-H2bYFP
were viral genome positive compared to 1 in 80 splenocytes from
wild type virus infected mice and 1 in 70 splenocytes from mice
infected with MHV68-YFP.
The ability to reactivate from latency was also determined by a
limiting dilution ex vivo reactivation assay (Fig. 2B). As expected,
there was no significant difference in the ability to reactivate from
latency between MHV68-H2bYFP and either wild type virus or
MHV68-YFP. Approximately 1 in 4,900 splenocytes were capable
of reactivating virus from mice infected with wild type virus
compared to 1 in 12,500 splenocytes from mice infected with
MHV68-YFP and 1 in 7,800 splenocytes from mice infected with
MHV68-H2bYFP. The observed differences are within the
normal variability that we have previously observed using this
assay (as we have previously documented, and as shown in Fig. 2D,
significant mouse to mouse variation in the frequency of virus
infected splenoctyes is observed – which necessitates pooling
splenocytes from 4–5 mice for assessment of latency) [4].
To assess whether expression of the H2bYFP fusion protein had
any impact on the ability to mark cells, the percentage of EYFP
positive B cells from mice infected with MHV8-H2bYFP was
compared to that of splenocytes from mice infected with MHV68-
YFP (Fig. 2 panels C & D). Notably, there was no difference in the
ability of MHV68-H2bYFP to mark B cells compared to MHV68-
YFP. Although there was some individual variation, there was no
significant difference in the average number of EYFP positive cells
from mice infected with MHV68-H2bYFP compared to MHV68-
YFP. At day 14 post-infection, the average number of EYFP
positive splenic B cells from mice infected with MHV68-YFP was
0.125% compared to 0.116% from mice infected with MHV68-
H2bYFP. By day 18 post-infection the percentage of EYFP
positive B cells had risen to 0.58% and 0.49% for MHV68-YFP
and MHV68-H2bYFP, respectively. Taken together, this data
shows that expression of the H2bYFP fusion protein does not
appear to have any impact on the ability of MHV68 to establish
infection, reactivate from latency or mark B cells.
Analysis of MHV68 infection of germinal center B cells
Analysis of the total germinal center B cell populations showed
that there was no significant difference in the average number of
GC B cells at either days 14, 16 or 18 post-infection in mice
infected with either wild type virus, MHV68-YFP or MHV68-
H2bYFP (Fig. 3A). The percentage of germinal center B cells rose
slightly from ca. 2% at day 14 to ca. 4% by day 18 post-infection.
Although the overall percentage of B cells exhibiting a germinal
center phenotype increased from days 14 to 18 post-infection, the
percentage of EYFP positive cells exhibiting a germinal center
phenotype remained relatively constant at ca. 70% at each time
point (Fig. 3B). Importantly, expression of the H2bYFP fusion
protein had no impact on the ability of MHV68-H2bYFP to gain
access to the germinal center population. There was also no
significant difference in the overall percentage of germinal center
B cells that were infected based on EYFP expression from mice
infected with MHV68-H2bYFP compared to MHV68-YFP
(Fig. 3C). However, there was some individual variation in the
percentage of infected germinal center cells, and in some animals
nearly 30% of their germinal center B cells were EYFP positive.
To determine if the increased percentage of infected germinal
center cells correlated with the overall level of infection, the
percentage of EYFP positive germinal center B cells was plotted
against the percentage of total EYFP positive B cells (as shown in
Fig. 2D). Notably, this analyses revealed a very strong correlation
between the overall levels of infection as measured by the percent
EYFP+ splenocytes, and the percentage of germinal center B cells
that were infected (Fig. 3D). Animals that had the highest
percentage of infected cells also had the largest proportion of
infected germinal center B cells. Conversely, in animals that had
relatively few EYFP positive B cells, infected germinal center cells
made up a small percentage of the total germinal center B cell
population.
Detection of H2bYFP positive cells in tissue sections
To assess H2bYFP expression in unfixed spleen sections, mice
were infected intranasally with 1,000 pfu of MHV68-H2bYFP. At
day 16 post-infection, spleens were harvested and sections were
analyzed for H2bYFP expression. While we have encountered
significant difficulties detecting EYFP expression in spleens from
mice infected with MHV68-YFP (not shown), we could easily
detect H2bYFP expression in spleen sections from mice infected
with MHV68-H2bYFP (Fig. 4). Figure 4A shows a representative
section co-stained with anti-CD19 to detect B cell follicles, as well
as anti-IgD to delineate germinal centers within follicles that have
down-regulated expression of IgD. Consistent with the phenotypic
analyses summarized in figure 2B, as well as previous reports that
the majority of infected splenocytes have a germinal center
phenotype [3,4], the majority of H2bYFP positive cells were found
in germinal centers - although a few H2bYFP positive cells were
found outside germinal centers. Both H2bYFP-positive and -
negative germinal centers were observed and, similar to variation
we see in the total number of EYFP positive B cells (see Fig. 2D),
there was considerable variation in the number of H2bYFP
positive germinal centers per section. In some animals, nearly all
germinal centers contained H2bYFP-positive cells, whereas in
others there were as few as 1–2 H2bYFP-positive germinal centers
per section. Additionally, there was significant variation in the
number of H2bYFP-positive cells per germinal center. Represen-
tative sections shown in figure 4, panels B-E, illustrate the wide
range in the number of H2bYFP-positive cells per germinal center
we observed.
To further localize H2bYFP-positive cells within specific
compartments of the germinal center, spleen sections were stained
with antibodies to various markers used to define specific
components of germinal centers. Figure 5 shows serial sections
through a representative germinal center. The sections have been
stained with anti-IgD to define the mantle zone surrounding the
germinal center, and anti-GFP to detect the H2bYFP fusion
protein being expressed in MHV68-H2bYFP infected cells. The T
cell zone, found adjacent to B cell follicles, is shown in row A and
was detected by staining with anti-Thy1.2. Within the germinal
center, centrocytes are found in the light zone - which forms distal
to the T cell zone and can be identified by the presence of
follicular dendritic cells stained with anti-FDC-M1 (row B). The
dark zone contains rapidly dividing centroblasts and forms
proximal to the T cell zone. These rapidly dividing cells readily
incorporate EdU, which can be used to define the dark zone (row
C). Notably, H2bYFP-positive cells could be detected throughout
the germinal center in both the light zone and dark zone, as well as
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e33230Figure 2. Expression of the H2bYFP fusion does not alter the ability of MHV68-H2bYFP to establish infection. A) Limiting dilution PCR
analysis to determine the frequency of viral genome positive splenocytes from mice infected with 1,000 pfu of the indicated virus and harvested at
16 days post-infection. B) Limiting dilution analysis to determine the frequency of splenocytes capable of reactivating virus. Serial dilutions of
splenocytes were plated on MEF indicator monolayers, and the presence of reactivating virus was determined by the presence of cytopathic effect
(CPE). C) Representative flow plots showing the gating strategy to determine the percentage of EYFP and H2bYFP positive B cells. D) Quantitation of
the percentage of EYFP and H2bYFP positive B cells at the indicated days post-infection from mice infected with the 1,000 pfu of the indicated virus.
Results shown in panels A and B are from 3 individual experiments with 3 to 5 mice per group. Error bars represent the standard error of the mean.
Each symbol in panel D represents a single mouse, and the horizontal bars represent the mean. Results are from 3 independent experiments with 3–5
mice per group.
doi:10.1371/journal.pone.0033230.g002
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indicated virus and spleens were harvested at the indicated day post-infection. A) Total germinal center B cell analysis. A representative flow plot
showing the gating strategy to identify total germinal center population is shown in the left panel. B cells were defined as CD19
+ CD95
HI GL7
HI.
Quantitation of the percentage of B cells with a germinal center phenotype is shown in the right panel. B) Percentage of EYFP and h2bYFP positive
cells that have a germinal center phenotype. Representative flow plot showing the gating strategy used to identify cells with a germinal center
phenotype in the EYFP and h2bYFP positive fraction is shown in the left panel. The percentage of EYFP and H2bYFP positive cells that have a
germinal center phenotype is shown in the right panel. C) Percentage of germinal center cells that are infected. A representative flow plot showing
the gating strategy to identify the percentage germinal center cells that are infected based on YFP expression (left panel). The percentage of germinal
Tracking MHV68 Infection In Vivo
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mantle zone and in the T cell zone (row A). There were also
H2bYFP positive cells at the border between the B cell follicle and
the T cell zone, a site where initial CD4 T cell help activates B
cells that then migrate into the B cell follicle to initiate the
germinal center reaction (reviewed in [16]). Notably, there
appeared to be two distinct populations of H2bYFP positive cells
- those that expressed high levels of H2bYFP and largely localized
to the light zone, and those that expressed lower levels of H2bYFP
and localized in the dark zone. As shown in figure 5 row D (a
higher magnification of the germinal center section shown in row
C), the H2bYFP positive cells and EdU positive cells (overlayed
without the staining IgD staining) allowed identification of infected
cells that were proliferating based on high level EdU incorpora-
tion. In the dark zone, the majority of H2bYFP positive cells were
also EdU positive, although there were a few that had no
detectable EdU incorporation. In the light zone, while a few
H2bYFP positive cells were EdU positive, many more were EdU
negative than was observed in the dark zone. The physical location
of the high versus low H2bYFP expressing cells, along with the
relative level of EdU incorporation, suggested that cells expressing
high levels of H2bYFP are centrocytes while those expressing
lower levels of H2bYFP low expressing cells are centroblasts.
To further assess whether the difference in H2bYFP expression
correlated with differences in surface phenotype, H2bYFP positive
GC cells were analyzed for expression of CXCR4 and CD86.
Centroblasts have been shown to be CXCR4
hi CD86
lo whereas
centrocytes are CXCR4
loCD86
hi [17]. Figure 6A shows the gating
strategy used to determine H2bYFP expression in these popula-
tions, along with the analysis of a representative MHV68-H2BYFP
infected mouse. Compiling the data from multiple infected mice
revealed a clear difference in H2bYFP expression in the
centroblast and centrocyte germinal center B cell populations at
days 14, 16 and 18 post-infection (Fig. 6B). Figure 6B shows the
mean fluorescence intensity (MFI) of H2bYFP in splenocytes from
representative experiments harvested at days 14, 16 and 18 post-
infection. Furthermore, quantitation of these populations revealed
that the majority of MHV68 infected germinal center cells exhibit
a centroblast phenotype (ca. 3:1 ratio of centroblasts to
centrocytes) (Fig. 6C).
Long term marking of latently infected B cells by MHV68-
H2bYFP
Because histone H2b-GFP fusion proteins have been shown to
be stably maintained in cells that cycle slowly [12], we reasoned
that the H2bYFP fusion protein may extend marking of infected
cells due to the fact that long term latency is maintained in
memory B cells - a cell population that is largely quiescent [3].
Notably, we have previously shown that although we can sort out
an EYFP positive population of infected cells from mice infected
with MHV68-YFP at day 42 post-infection, there was a significant
fraction of viral genome positive cells that no longer had detectable
levels of YFP expression [4]. Indeed, from 2 independent analyses
only ca. 6,600 and 6,800 YFP+ cells were isolated from a total of
12 pooled spleens (the theoretical number of infected cells in these
samples ranged from 1.5–2.7610
5 cells based on limiting dilution
analyses of bulk splenocytes) [4]. Thus, less than 5% of MHV68
infected cells at day 42 post-infection with the MHV68-YFP virus
were recovered, suggesting inefficient EYFP expression at this late
time post-infection. Here we repeated this analysis using 10 pooled
spleens harvested at day 42 post-infection with MHV68-H2bYFP.
We were able to purify 1.25610
5 H2bYFP positive splenocytes
from a total of 7610
8 cells. This yield of H2bYFP positive cells
closely correlated with the theoretical number of MHV68 infected
cells (1.94610
5) as determined by limiting dilution analysis of the
bulk splenocyte population and the total number of cells sorted
(estimated recovery of ca. 65% of virus infected cells). Analysis of
the H2bYFP positive cell population by limiting dilution for the
presence of the MHV68 genome revealed that, within the likely
error of the limiting dilution assay, virtually all recovered cells
harbored viral genome (frequency of H2bYFP positive cells
recovered that harbored viral genome was estimated to be 1 in
2.4) (Fig. 7). Furthermore, we observed a significant reduction in
the frequency of viral genome positive cells in the H2bYFP-
negative splenocyte fraction (1 in 27,000 cells) compared to the
center cells that were infected is shown in the right panel. D) Correlation between the percentage of EYFP and H2bYFP positive B cells and the
percentage of EYFP and H2bYFP positive germinal center cells. In the right panels of A, B and C, the horizontal bar represents the mean.
doi:10.1371/journal.pone.0033230.g003
Figure 4. Detection of H2bYFP positive cells in unfixed spleen
sections. A) Representative spleen section from a mouse infected with
1,000 pfu of MHV68-H2bYFP and harvested at day 16 post-infection. B–
E) H2bYFP positive germinal centers demonstrating the variability in the
number of infected cells per germinal center. Images were collected at
a magnification of 1006in A, 3206in B–D, and 2006in E.
doi:10.1371/journal.pone.0033230.g004
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of MHV68 infected cells were H2bYFP positive. Thus, unlike the
MHV68-YFP virus which efficiently marks latently infected
splenocytes only at the early stages of latency, infection with the
MHV68-H2bYFP virus extends the time frame of efficient
marking of infected splenocytes to at least 6 weeks post-infection.
Conclusions
In this report we describe a new strategy to mark cells infected
with MHV68 that allows both long term marking, as well as
detection of infected cells in unfixed tissue sections. The ability to
correlate surface phenotype with physical location within tissue
sections provides a new tool to study gammaherpesvirus
pathogenesis. It also simplifies detection of virus infected cells
since it eliminates the need for optimizing fixation of different
tissue types. Furthermore, the morphology of the sections is well
maintained and signal loss due to over-fixation of antigens is not
an issue.
We have focused on splenic latency since the spleen is a rich
source of infected cells during the early establishment of latency.
However, we have also been able to detect MHV68-H2bYFP
infected cells in unfixed sections of lymph nodes (C.M. Collins and
S.H. Speck, unpublished data) as well as the omentum (K. S. Gray
and S. H. Speck, unpublished data). It should be noted that while
cell types such as macrophages and dendritic cells have been
shown to harbor viral genome [2,3,18,19] which are present in the
spleen at the peak of viral latency, we have not been able to
convincingly detect EYFP or H2bEYFP transgene expression in
these cell types. To date we have only detected MHV68 infected B
cells and plasma cells using either the MHV68-YFP or MHV68-
H2bYFP viruses. This may reflect: (i) cell type specific activity of
the HCMV IE promoter driving transgene expression; (ii) the low
frequency of viral genome positive macrophages and dendritic
cells present in the spleen at the peak of viral infection [2,3]; and/
or (iii) that MHV68 infection of these cells types is non-productive
and does not result in significant transcription from the viral
genome. Notably, previous reports have shown that the frequency
of viral genome positive cells in these populations is very low [2],
which would be very difficult to detect by flow cytometry above
background auto-fluorescence. However, we have also failed to
Figure 5. Localization of H2bYFP positive cells within germinal centers. Serial sections through a representative splenic GC recovered at day
16 post-infection, co-stained with markers to localize infected cells within specific germinal center compartments. Sections were stained with anti-
IgD to delineate the mantle zone surrounding the GC and anti-GFP to detect infected cells. To detect the T cell zone, sections were co-stained with
anti-Thy 1.2 (row A). The light zone is detected by the presence of follicular dendritic cells stained with anti-FDC-M1 (row B). Rapidly dividing
centroblasts are found in the dark zone, and can be detected by increased incorporation of EdU (row C). Row D shows the h2bYFP and EdU panels
from row C overlayed without IgD to identify proliferating H2bYFP positive cells.
doi:10.1371/journal.pone.0033230.g005
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intraperitoneal inoculation (data not shown) – an anatomical site
where we have shown that a majority of the MHV68 infected cells
are macrophages [19]. The latter argues that there is little or no
expression of the EYFP and H2bYFP transgenes in MHV68
infected macrophages.
We do not know why there is such extreme variation in level of
MHV68 infection of germinal centers. Newly activated B cells
have been shown to be able to enter existing germinal centers [20],
so it is possible that germinal centers with few infected cells (for
example see Fig. 4B,C) may result from colonization of existing
germinal centers by infected cells. In germinal centers with high
levels of infection (see Fig. 4E), infected B cells may be responsible
for the initiation of these germinal centers. It will be of interest to
determine whether the H2bYFP positive cells in individual
germinal centers with high levels of infected cells are clonal,
which would indicate that they arose from single infected B cells.
Previously, cells infected with MHV-68 in lymphoid tissues have
been detected by in situ hybridization using probes that detect the
presence of vtRNAs [21–23]. A recent report characterizing
MHV68 infection in wood mice indicated that the majority of
infected cells in germinal centers were localized to the light zone
based on the distribution of viral tRNAs (vtRNAs) positive cells
[24]. However, as discussed above, we noted two distinct
Figure 6. Characterization of infected centroblast and centrocyte populations. A) Gating strategy used to identify YFP positive centroblasts
and centrocytes (left panel). Representative histogram showing YFP expression in centroblasts and centrocyts (right panel). B) Mean fluorescence
intensities of YFP in centroblasts and centrocytes at days 14, 16 and 18 post-infection. Each graph shows one representative experiment with 4 to 5
mice per group. H2bYFP MFI was analyzed in at least 3 independent experiments at each time point with similar results. C) Quantitation of H2bYFP
positive centroblast and centrocyte populations at the indicated days post-infection.
doi:10.1371/journal.pone.0033230.g006
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H2bYFP expression – which reflected differences in the levels of
H2bYFP expression in centroblasts vs centrocytes (see Fig. 6).
Although this could reflect differences in transcription of the
H2bYFP transcription in these two B cell populations, it is more
likely that it reflects the high rate of proliferation of centroblasts
leading to dilution of H2bYFP levels in these cells. If the latter is
true, it is tempting to speculate that rapidly dividing centroblasts
also express low levels of the vtRNAs and thus leading to a failure
to detect MHV68 infected centroblasts by in situ hybridization.
Indeed, it seems very likely that gammaherpesviruses have evolved
to take advantage of the germinal center reaction as a means to
expand the pool of latently infected B cells – some of which
ultimately gain access to the memory B cell reservoir. As observed
in classical T cell responses, there is a significant contraction in the
frequency of MHV68 B cell latency from a peak at ca. 2 weeks
post-infection (ca. 1 in 100) to the steady-state level established by
3 months post-infection (ca. 1 in 10,000) [3]. This contraction may
reflect immune clearance of some population(s) of MHV68 latently
infected B cells, and/or the intrinsic inefficiency in the transition of
germinal center B cells to the memory B cell pool. We anticipate
that the MHV68-H2bYFP virus described here will a useful tool in
beginning to unravel this issue.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Emory University Institutional
Animal Care and Use Committee, and in accordance with
established guidelines and policies at Emory University School of
Medicine (Protocol Number: 046-2010).
Viruses and tissue culture
Wild type MHV-68 strain WUMS (ATCC VR-1465) was used
for all wild type infections. Virus propagation and titer
determination was performed as previously described [25].
NIH3T12 cells were obtained from ATCC (CCL-164) and
Vero-Cre cells were generous gift from Dr. David Leib [26].
Murine embryonic fibroblasts (MEFs) were generated from
homogenized day 16 C57Bl6 embryos cultivated in complete
DMEM as previously described [27]. NIH3T12, Vero-Cre, and
murine embryonic fibroblasts (MEFs) were maintained in
Dulbecco’s modification of Eagle medium (DMEM) supplemented
with 10% fetal bovine serum, 2 mM L-glutamine, and 100 U of
penicillin and 100 mg of streptomycin per ml.
Mice, infections and tissue harvest
Female C57BL/6J mice were purchased from Jackson Labora-
tory (Bar Harbor, ME) at 6 to 8 weeks of age and were infected at
8 to 12 weeks. All protocols utilized in this study were approved by
the Institutional Animal Care and Use Committee of Emory
University. Mice were anesthetized with isofluorane prior to
infection and inoculated intranasally with 1,000 pfu of virus that
was diluted in 20 mL of DMEM.
Construction of MHV68-H2bYFP
To generate a histone h2bYFP fusion protein, the histone h2b
openreading frame wasPCR amplified fromgenomic DNApurified
from splenocytes isolated from C57Bl6 mice using the primers H2B
For_PstI (59-CCGCCTGCA GACCATGCCCGAGCCTGCG-39)
and H2B_linker Rev (59-ACTACCTCTTACACACTTGGAG
CTGGTGTACTTAGTGACAGC-39). The EYFP open reading
frame was PCR amplified using the primers linker-YFP-For (59-
TGTGTAAGAGGTAGTATGGTGAGCAAGGGCGAGGAGC-
TG-39) and YFP-Rev-NotI (59-CCGCGCGGCCGCCCCCAGC-
TGGTTCTTTC-39). Primers were designed to incorporate a 15
nucleotide linker at the 39 end of the h2b orf and at the 59 end on the
EYFP orf. This linker sequence was then used for overlapping PCR
with the primers H2B For_PstI and YFP-Rev-NotI to generate the
H2bYFP fusion protein. The H2bYFP PCR product was digested
with the restriction enzymes PstI and NotI and cloned into the PstI-
NotI site of the previously described pCR-Blunt-Ins-CMV-YFP [4]
to create pCR-Blunt-Ins-CMV-H2bYFP. The fragment spanning
the hCMV IE promoter to the bovine growth hormone polyade-
nylation signal was then purfied by digestion of pCR-Blunt-Ins-
CMV-H2bYFP with the restriction enzymes NsiI and NotI. This
fragment was cloned into the NsiI NotI fragment of the previously
described JE110-XL9CD CMV-YFP-R [4] to generate JE110-X-
CMV-H2bYFP. The ApaI fragment from this vector was then
cloned into the ApaI site of pGS284-Blunt-MCS [4] to generate
pGS284-XL9CD-CMV-H2bYFP. This vector was then used for
allelic exchange with wild-type MHV68 BAC in GS500, a RecA+
strain of E. coli.
Limiting dilution PCR analysis
To determine the frequency of viral genome positive splenocytes,
limiting dilution PCR analysis using a single copy sensitive nested
PCR assay was performed as previously described [16,17]. Briefly,
serial three-fold dilutions of splenocytes were plated in 96 well plates
in a background of 10
4 uninfected NIH3T2 cells. Cells were lysed
by proteinase K digestion for 6 hours at 56uC followed by heat
inactivation at 95uC for 20 minutes. Sampleswere then subjected to
2 rounds of PCR using nested primers as previously described
[18,27]. To ensure single copy sensitivity, plasmid controls
consisting of 10, 1, and 0.1 copies of the orf50 containing plasmid
pBamHIN were spiked into a background of 10
4 uninfected
NIH3T12 cells. PCR products were analyzed on a 2% agarose gel.
Limiting dilution ex vivo reactivation
To determine the frequency of splenocytes capable of
reactivating virus, limiting dilution analysis was performed as
Figure 7. Long term marking of splenocytes infected with
MHV68-H2bYFP. YFP+ and YFP2 splenocytes from mice were sorted
at 42 days post-infection from mice infected with 1,000 pfu of MHV68-
H2bYFP. Limiting dilution PCR analysis was performed to determine the
frequency of viral genome positive cells in each fraction.
doi:10.1371/journal.pone.0033230.g007
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complete DMEM and plated onto indicator MEF monolayers in
serial two-fold dilutions, beginning with 10
5 splenocytes per well.
Wells were scored for cytopathic effect 14 days after plating. To
detect the presence of preformed infectious virus, parallel samples
of mechanically disrupted splenocytes were also plated on MEF
monolayers.
Flow cytometry
Single cell suspensions of splenocytes were resuspended in
phosphate-buffered saline containing 1% fetal bovine serum and
stained for 20 minutes on ice in the dark. Antibodies used were
phycoerythrin conjugated and-CD138 (BD Pharmingen), PerCP
conjugated anti-CD3 (BD Pharmingen), phycoerythrin Cy7
conjugated anti-CD95 (BD Pharmingen), Pacific blue conjugated
anti- B220 (Invitrogen), phycoerythrin conjugated anti-CD19 (BD
Pharmingen), allophycocyanin conjugated anti-GL7 (eBioscience).
Biotin conjugated anti GL7 was detected with allophycocyanin
conjugated streptavidin (Invitrogen). Data were acquired on an
LSRII flow cytometer (BD Biosciences) and analyzed on FloJo
software (Treestar, Inc., San Carlos, CA).
For fluorescence activated cell sorting, splenocytes from 10
pooled spleens from mice infected with 1,000 pfu of MHV68-
H2bYFP and harvested at 16 days post-infection were resus-
pended at a concentration of 1610
8 cells per ml in PBS containing
1% fetal bovine serum. Cells were sorted on a FACSAria (BD
Biosciences) and sorted populations were immediately plated out
for LD-PCR analysis.
Tissue section preparation and immunofluoresence
microscopy
Spleens from infected mice were harvested and embedded in
OCT media (Sakura Finetek) by flash freezing themin chilled-
isopentane (Fisher Scientific). Frozen sections were cut at a
thickness of 5 mm, mounted on glass slides and stored at 280uC
until needed. Sections were re-hydrated at room temperature in
PBS for 10 minutes and then blocked with PBS containing 3%
BSA for 20 minutes at room temperature. H2bYFP was detected
in sections using a FITC conjugated anti-GFP antibody (Rockland
Immunochemicals for Research). Antibodies to cellular antigens
were purified anti-IgD(BD Pharmingen), purified anti-FDC-
M1(BD Pharmingen), Alexa647 conjugated anti-IgD (Biolegend),
phycoerythrin conjugated anti-CD19 (BD Pharmingen), and
allophycocyanin conjugated anti-Thy1.2 (BD Pharmingen). Puri-
fied antibodies were detected with Alexa 546 conjugated anti-rat
IgG (Invitrogen). After staining, sections were mounted with
Prolong antifade reagent with DAPI (Invitrogen). Images were
collected on a Zeiss Axiovert 200 M fluorescent scope using
Axiovision imaging software.
EdU labeling
To detect replicating cells in spleen sections, mice were treated
with 59-ethynyl- 29-deoxyuridine (EdU) (Invitrogen) for 5 hours by
intra-peritoneal injection of 100 mg of EdU in PBS. Cells that had
incorporated EdU were detected with a Click-it EdU Alexa Fluor
555 Imaging kit (C10338) from Invitrogen according to the
manufacturer’s protocol with the following modifications. Sections
were stained with fluorophore conjugated antibodies and subse-
quently fixed with 4% paraformaldehyde in PBS for 10 minutes at
room temperature. After fixation, sections were permeabilized
with 0.5% Triton X-100 in PBS for 15 minutes at room
temperature, and EdU detection was then performed according
to the manufacturer’s protocol.
Statistical analysis
All data analysis was performed using GraphPad Prism software
(GraphPad Software, San Diego, CA). The frequencies of genome
positive splenocytes and splenocytes capable of reactivation virus
were determined by non-linear regression fit of the data where the
regression line intersected 63.2%, corresponding to the frequency
at which one event is predicted to be present in that population.
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